Mar 05, 2019 / 01:30PM GMT
Operator
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Aerpio Pharmaceuticals Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call.
It is now my pleasure to turn the call over to Michael Rogers, Aerpio's Chief Financial Officer. Please go ahead, sir.
Michael W. Rogers - Aerpio Pharmaceuticals, Inc. - CFO
Okay, Dimitris. Thank you. Good morning, and thank you for joining us for Aerpio's Fourth Quarter and Full Year 2018 Earnings Call.
Joining me on the call today is -- from Aerpio is Steve Hoffman, the Chief Executive Officer; Joseph Gardner, our President and Founder; Steve Pakola, our Chief Medical Officer; and Kevin Peters, our Chief Scientific Officer.
This morning, Aerpio released financial results for the fourth quarter and full year ended December 31, 2018. If you've not received the news release or if you'd like to be added to the company's distribution list, you can do so on our Investor Relations page of our website at aerpio.com.
I would also like to remind
Q4 2018 Aerpio Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot